Status:

ACTIVE_NOT_RECRUITING

An Innovative Conversational Agent (Quitbot) for Smoking Cessation

Lead Sponsor:

Fred Hutchinson Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Cigarette Smoking-Related Carcinoma

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.

Detailed Description

OUTLINE: Participants are randomized to 1 of 2 groups. Both groups receive access to a 42-day quit smoking program. GROUP I: Experimental program, for 42 days to support quitting smoking. After the ...

Eligibility Criteria

Inclusion

  • Age 18 or older
  • Smokes at least one cigarette a day for the past 12 months
  • Wants to quit cigarette smoking within the next 30 days (consistent with text messaging intervention trials)
  • If concurrently using any other nicotine or tobacco products, wants to quit using them within the next 30 days
  • Interested in learning skills to quit smoking
  • Willing to be randomly assigned to either intervention
  • Resides in United States (US) and will continue to reside in the US for the next 12 months
  • Has at least daily access to their own smartphone
  • Has text messaging on their smartphone and knows how to download a smartphone application
  • Willing and able to read in English, and
  • Not using other smoking cessation interventions (This eligibility requirement helps ensure results are due to the treatments we recommend rather than those that participants are doing on their own.)

Exclusion

  • The reverse of the inclusion criteria

Key Trial Info

Start Date :

July 24 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2026

Estimated Enrollment :

1647 Patients enrolled

Trial Details

Trial ID

NCT04308759

Start Date

July 24 2022

End Date

May 1 2026

Last Update

May 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States, 98109